Cancel
Ian M. Estepan
Executive Vice President, Chief Financial Officer
@
Sarepta Therapeutics
q7.08z5j20@dz20wb4.29w
Sign up to see email
Known information
- Recipient of the 2022 CFO of the Year award from the Boston Business Journal
- Witnessing a child with Duchenne get on therapy was one of the best days of his life, second only to the birth of his own son
About Sarepta Therapeutics
Sarepta Therapeutics is a biotechnology company specializing in precision genetic medicine for rare diseases, with over 40 investigational therapies and FDA-approved treatments for Duchenne muscular dystrophy.
Report inaccurate information
